The Risk of Developing Long COVID in Patients With Inflammatory Bowel Diseases: Do Immunosuppressive Drugs Matter? Bourgonje AR, Otten AT. Clin Gastroenterol Hepatol 2023;21:1971-1972.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Bourgonje AR, Otten AT. The Risk of Developing Long COVID in Patients With Inflammatory Bowel Diseases: Do Immunosuppressive Drugs Matter? Clin Gastroenterol Hepatol 2023;21:1971-1972.
PMID: 36642294